Danaher Corporation (DHR)
LH or DHR: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock
Danaher Corp (NYSE:DHR) on Tuesday reported first-quarter 2026 sales of $5.95 billion, up 3.5% year-over-year, but under the consensus of $5.99 billion. Core revenue increased 0.5% year-over-year.
Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript
Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript
Danaher (DHR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock?
DHR heads into Q1 results with rising bioprocessing demand and steady estimates, but cost pressures and FX headwinds could weigh on performance.
Ahead of Danaher (DHR) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors
Danaher is an American healthcare company that manufactures and markets products used for advances in biotechnology, life sciences, and diagnostics. Danaher has increased its dividend for 13 consecutive years. And its dividend growth has been nothing short of spectacular. DHR has a strong financial position. Its long-term debt/equity ratio is 0.3, while the interest coverage ratio is 17.
Bamco Inc. NY Decreases Stock Holdings in Danaher Corporation $DHR
Bamco Inc. NY lowered its stake in Danaher Corporation (NYSE: DHR) by 36.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,329 shares of the conglomerate's stock after selling 26,807 shares during the quarter. Bamco Inc. NY's holdings in Danaher were worth
Bank of Nova Scotia Sells 248,580 Shares of Danaher Corporation $DHR
Bank of Nova Scotia decreased its position in shares of Danaher Corporation (NYSE: DHR) by 54.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,365 shares of the conglomerate's stock after selling 248,580 shares during the
Banco Bilbao Vizcaya Argentaria S.A. Has $14.18 Million Stock Position in Danaher Corporation $DHR
Banco Bilbao Vizcaya Argentaria S.A. grew its stake in Danaher Corporation (NYSE: DHR) by 63.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,032 shares of the conglomerate's stock after buying an additional 27,834 shares during the quarter. Banco Bilbao Vizcaya Argentaria
Danaher Corporation $DHR Shares Purchased by Ameriprise Financial Inc.
Ameriprise Financial Inc. increased its holdings in shares of Danaher Corporation (NYSE: DHR) by 211.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,088,089 shares of the conglomerate's stock after buying an additional 1,418,243 shares during the quarter. Ameriprise Financial
